Vascular Pathways, a US-based medical device company, has raised $14m in its series B round from a consortium including Ascension Health Ventures, the corporate venturing division of Ascension Health and Catholic healthcare organisations.
Venture capital firm CHL Medical Partners led the B round, with the other syndicate members including peers MVM Life Science Partners and Arcus Ventures. Walter Lin, investment manager at Ascension Health Ventures, has joined Vascular’s board, along with Myles Greenberg of CHL and Stephen Reeders of MVM.
Vascular said its B round would bring its Rapid Intravascular Start IV product to market in a sector where more than 300 million peripheral intravenous catheters are placed in patients in the US each year.